Skin treatment devices and methods with pre-stressed configurations
US-2018360669-A1 · Dec 20, 2018 · US
Asp- or Asn-amino acid
Asp- or Asn-amino acid · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K5/06113 |
| Official title | {Asp- or Asn-amino acid} |
| Display label | Asp- or Asn-amino acid |
| Total patents | 107 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 14 |
| 2016 | 15 |
| 2017 | 12 |
| 2018 | 19 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 13 |
| 2025 | 5 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
US-10155789-B2 · Dec 18, 2018 · US
Conjugates for treating diseases caused by psma expressing cells
US-2018289826-A1 · Oct 11, 2018 · US
Conjugates for treating diseases caused by psma expressing cells
US-2018271991-A1 · Sep 27, 2018 · US
Conjugates for treating diseases caused by psma expressing cells
US-2018256733-A1 · Sep 13, 2018 · US
Conjugates for treating diseases caused by psma expressing cells
US-2018256734-A1 · Sep 13, 2018 · US
PSMA Imaging Agents
US-2018258134-A1 · Sep 13, 2018 · US
Conjugates for treating diseases caused by psma expressing cells
US-2018256735-A1 · Sep 13, 2018 · US
Conjugates for treating diseases caused by psma expressing cells
US-2018256736-A1 · Sep 13, 2018 · US
Conjugates for treating diseases caused by psma expressing cells
US-2018256737-A1 · Sep 13, 2018 · US
Amphiphilic linear peptide/peptoid and hydrogel comprising the same
US-10071183-B2 · Sep 11, 2018 · US
Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators
US-2018228772-A1 · Aug 16, 2018 · US
PSMA imaging agents
US-10011632-B2 · Jul 3, 2018 · US
Dipeptides as inhibitors of human immunoproteasomes
US-9988421-B2 · Jun 5, 2018 · US
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
US-9974772-B2 · May 22, 2018 · US
Pro-substrates for live cell applications
US-9927430-B2 · Mar 27, 2018 · US
LIPID ASSEMBLIES AND USES THEREOF AND SOME pH AND ELECTROSTATIC MODULATING LIPIDS TO BE USED IN SAID ASSEMBLIES
US-2018043036-A1 · Feb 15, 2018 · US
Skin treatment devices and methods with pre-stressed configurations
US-9889046-B2 · Feb 13, 2018 · US
Methods of treating cancer with a psma ligand-tubulysin compound
US-2018036364-A1 · Feb 8, 2018 · US
Biologically active c-terminal arginine-containing peptides
US-2017321187-A1 · Nov 9, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K5/06113?
- CPC C07K5/06113 is the Cooperative Patent Classification code for “Asp- or Asn-amino acid.”
- How many patents are filed under CPC C07K5/06113 (Asp- or Asn-amino acid)?
- Our database includes 107 publications tagged with this CPC code.
- Is patent activity under CPC C07K5/06113 growing?
- Publication counts under this code: 13 in 2024 vs 5 in 2025 (latest complete years).